-
1
-
-
0036366824
-
Classifying the medulloblastoma: insights from morphology and molecular genetics
-
Ellison D: Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 2002, 28: 257-282.
-
(2002)
Neuropathol Appl Neurobiol
, vol.28
, pp. 257-282
-
-
Ellison, D.1
-
2
-
-
0037273964
-
What's new in neuro-oncology? Recent advances in medulloblastoma
-
Ellison DW, Clifford SC, Gajjar A, Gilbertson RJ: What's new in neuro-oncology? Recent advances in medulloblastoma. Eur J Paediatr Neurol 2003, 7: 53-66.
-
(2003)
Eur J Paediatr Neurol
, vol.7
, pp. 53-66
-
-
Ellison, D.W.1
Clifford, S.C.2
Gajjar, A.3
Gilbertson, R.J.4
-
3
-
-
84860821444
-
Molecular subgroups of medulloblastoma: the current consensus
-
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, et al.: Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 2012, 123: 465-472.
-
(2012)
Acta Neuropathol
, vol.123
, pp. 465-472
-
-
Taylor, M.D.1
Northcott, P.A.2
Korshunov, A.3
Remke, M.4
Cho, Y.J.5
Clifford, S.C.6
Eberhart, C.G.7
Parsons, D.W.8
Rutkowski, S.9
Gajjar, A.10
-
4
-
-
80955180712
-
A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25)
-
Gajjar AJ, Stewart CF, Ellison DW, Curran T, Phillips P, Goldman S, Packer R, Kun LE, Boyett JM, Gilbertson RJ: A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25). J Clin Oncol 2010, 28: 18s.
-
(2010)
J Clin Oncol
, vol.28
-
-
Gajjar, A.J.1
Stewart, C.F.2
Ellison, D.W.3
Curran, T.4
Phillips, P.5
Goldman, S.6
Packer, R.7
Kun, L.E.8
Boyett, J.M.9
Gilbertson, R.J.10
-
5
-
-
79954577056
-
A phase I dose-escalation study of LDE225, a smoothened (Smo) antagonist, in patients with advanced solid tumors
-
Rodon Ahnert J, Baselga J, Tawbi HA, Shou Y, Granvil C, Dey J, Mita MM, Thomas AL, Amakye DD, Mita AC: A phase I dose-escalation study of LDE225, a smoothened (Smo) antagonist, in patients with advanced solid tumors. J Clin Oncol 2010, 28: 15s.
-
(2010)
J Clin Oncol
, vol.28
-
-
Rodon Ahnert, J.1
Baselga, J.2
Tawbi, H.A.3
Shou, Y.4
Granvil, C.5
Dey, J.6
Mita, M.M.7
Thomas, A.L.8
Amakye, D.D.9
Mita, A.C.10
-
6
-
-
70349244812
-
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449
-
Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, et al.: Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009, 361: 1173-1178.
-
(2009)
N Engl J Med
, vol.361
, pp. 1173-1178
-
-
Rudin, C.M.1
Hann, C.L.2
Laterra, J.3
Yauch, R.L.4
Callahan, C.A.5
Fu, L.6
Holcomb, T.7
Stinson, J.8
Gould, S.E.9
Coleman, B.10
-
7
-
-
77953723856
-
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
-
Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M, Taylor MD, von Deimling A, et al.: HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Canc Res 2010, 16: 3240-3252.
-
(2010)
Clin Canc Res
, vol.16
, pp. 3240-3252
-
-
Milde, T.1
Oehme, I.2
Korshunov, A.3
Kopp-Schneider, A.4
Remke, M.5
Northcott, P.6
Deubzer, H.E.7
Lodrini, M.8
Taylor, M.D.9
von Deimling, A.10
-
8
-
-
63449115501
-
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
-
Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et al.: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009, 41: 465-472.
-
(2009)
Nat Genet
, vol.41
, pp. 465-472
-
-
Northcott, P.A.1
Nakahara, Y.2
Wu, X.3
Feuk, L.4
Ellison, D.W.5
Croul, S.6
Mack, S.7
Kongkham, P.N.8
Peacock, J.9
Dubuc, A.10
-
9
-
-
79251629946
-
The genetic landscape of the childhood cancer medulloblastoma
-
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, et al.: The genetic landscape of the childhood cancer medulloblastoma. Science 2011, 331: 435-439.
-
(2011)
Science
, vol.331
, pp. 435-439
-
-
Parsons, D.W.1
Li, M.2
Zhang, X.3
Jones, S.4
Leary, R.J.5
Lin, J.C.6
Boca, S.M.7
Carter, H.8
Samayoa, J.9
Bettegowda, C.10
-
10
-
-
84864419974
-
Dissecting the genomic complexity underlying medulloblastoma
-
Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stutz AM, et al.: Dissecting the genomic complexity underlying medulloblastoma. Nature 2012, 488: 100-105.
-
(2012)
Nature
, vol.488
, pp. 100-105
-
-
Jones, D.T.1
Jager, N.2
Kool, M.3
Zichner, T.4
Hutter, B.5
Sultan, M.6
Cho, Y.J.7
Pugh, T.J.8
Hovestadt, V.9
Stutz, A.M.10
-
11
-
-
84878857067
-
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
-
Dubuc AM, Remke M, Korshunov A, Northcott PA, Zhan SH, Mendez-Lago M, Kool M, Jones DT, Unterberger A, Morrissy AS, et al.: Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 2012, 125: 373-84.
-
(2012)
Acta Neuropathol
, vol.125
, pp. 373-384
-
-
Dubuc, A.M.1
Remke, M.2
Korshunov, A.3
Northcott, P.A.4
Zhan, S.H.5
Mendez-Lago, M.6
Kool, M.7
Jones, D.T.8
Unterberger, A.9
Morrissy, A.S.10
-
12
-
-
11144332565
-
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
-
Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119: 941-953.
-
(2004)
Cell
, vol.119
, pp. 941-953
-
-
Shi, Y.1
Lan, F.2
Matson, C.3
Mulligan, P.4
Whetstine, J.R.5
Cole, P.A.6
Casero, R.A.7
-
13
-
-
24144462170
-
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
-
Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule R: LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437: 436-439.
-
(2005)
Nature
, vol.437
, pp. 436-439
-
-
Metzger, E.1
Wissmann, M.2
Yin, N.3
Muller, J.M.4
Schneider, R.5
Peters, A.H.6
Gunther, T.7
Buettner, R.8
Schule, R.9
-
14
-
-
24944535335
-
Regulation of LSD1 histone demethylase activity by its associated factors
-
Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y: Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005, 19: 857-864.
-
(2005)
Mol Cell
, vol.19
, pp. 857-864
-
-
Shi, Y.J.1
Matson, C.2
Lan, F.3
Iwase, S.4
Baba, T.5
Shi, Y.6
-
15
-
-
34247348215
-
Opposing LSD1 complexes function in developmental gene activation and repression programmes
-
Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, et al.: Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446: 882-887.
-
(2007)
Nature
, vol.446
, pp. 882-887
-
-
Wang, J.1
Scully, K.2
Zhu, X.3
Cai, L.4
Zhang, J.5
Prefontaine, G.G.6
Krones, A.7
Ohgi, K.A.8
Zhu, P.9
Garcia-Bassets, I.10
-
16
-
-
84865339061
-
Targeting the enhancer of zeste homologue 2 in medulloblastoma
-
Alimova I, Venkataraman S, Harris P, Marquez VE, Northcott PA, Dubuc A, Taylor MD, Foreman NK, Vibhakar R: Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Canc 2012, 131: 1800-1809.
-
(2012)
Int J Canc
, vol.131
, pp. 1800-1809
-
-
Alimova, I.1
Venkataraman, S.2
Harris, P.3
Marquez, V.E.4
Northcott, P.A.5
Dubuc, A.6
Taylor, M.D.7
Foreman, N.K.8
Vibhakar, R.9
-
17
-
-
84870573126
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
-
McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A 3rd, Diaz E, et al.: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012, 492: 108-112.
-
(2012)
Nature
, vol.492
, pp. 108-112
-
-
McCabe, M.T.1
Ott, H.M.2
Ganji, G.3
Korenchuk, S.4
Thompson, C.5
Van Aller, G.S.6
Liu, Y.7
Graves, A.P.8
Della Pietra, A.9
Diaz, E.10
-
18
-
-
62449197931
-
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy
-
Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L, Kuhfittig-Kulle S, et al.: Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Canc Res 2009, 69: 2065-2071.
-
(2009)
Canc Res
, vol.69
, pp. 2065-2071
-
-
Schulte, J.H.1
Lim, S.2
Schramm, A.3
Friedrichs, N.4
Koster, J.5
Versteeg, R.6
Ora, I.7
Pajtler, K.8
Klein-Hitpass, L.9
Kuhfittig-Kulle, S.10
-
19
-
-
33845762289
-
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
-
Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, et al.: Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Canc Res 2006, 66: 11341-11347.
-
(2006)
Canc Res
, vol.66
, pp. 11341-11347
-
-
Kahl, P.1
Gullotti, L.2
Heukamp, L.C.3
Wolf, S.4
Friedrichs, N.5
Vorreuther, R.6
Solleder, G.7
Bastian, P.J.8
Ellinger, J.9
Metzger, E.10
-
20
-
-
77950868547
-
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
-
Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R, Kirfel J: Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010, 31: 512-520.
-
(2010)
Carcinogenesis
, vol.31
, pp. 512-520
-
-
Lim, S.1
Janzer, A.2
Becker, A.3
Zimmer, A.4
Schule, R.5
Buettner, R.6
Kirfel, J.7
-
21
-
-
80054684268
-
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors
-
Schildhaus HU, Riegel R, Hartmann W, Steiner S, Wardelmann E, Merkelbach-Bruse S, Tanaka S, Sonobe H, Schule R, Buettner R, Kirfel J: Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol 2011, 42: 1667-1675.
-
(2011)
Hum Pathol
, vol.42
, pp. 1667-1675
-
-
Schildhaus, H.U.1
Riegel, R.2
Hartmann, W.3
Steiner, S.4
Wardelmann, E.5
Merkelbach-Bruse, S.6
Tanaka, S.7
Sonobe, H.8
Schule, R.9
Buettner, R.10
Kirfel, J.11
-
22
-
-
52449119078
-
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
-
Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, et al.: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008, 3: e3088.
-
(2008)
PLoS One
, vol.3
-
-
Kool, M.1
Koster, J.2
Bunt, J.3
Hasselt, N.E.4
Lakeman, A.5
van Sluis, P.6
Troost, D.7
Meeteren, N.S.8
Caron, H.N.9
Cloos, J.10
-
23
-
-
33646429798
-
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS
-
Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, Foster AC, Zlotnik A: Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 2006, 7: 67-80.
-
(2006)
Neurogenetics
, vol.7
, pp. 67-80
-
-
Roth, R.B.1
Hevezi, P.2
Lee, J.3
Willhite, D.4
Lechner, S.M.5
Foster, A.C.6
Zlotnik, A.7
-
24
-
-
34548513035
-
p53 is regulated by the lysine demethylase LSD1
-
Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T, Berger SL: p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449: 105-108.
-
(2007)
Nature
, vol.449
, pp. 105-108
-
-
Huang, J.1
Sengupta, R.2
Espejo, A.B.3
Lee, M.G.4
Dorsey, J.A.5
Richter, M.6
Opravil, S.7
Shiekhattar, R.8
Bedford, M.T.9
Jenuwein, T.10
Berger, S.L.11
-
25
-
-
84862888097
-
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
-
Kunkele A, De Preter K, Heukamp L, Thor T, Pajtler KW, Hartmann W, Mittelbronn M, Grotzer MA, Deubzer HE, Speleman F, et al.: Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro Oncol 2012, 14: 859-869.
-
(2012)
Neuro Oncol
, vol.14
, pp. 859-869
-
-
Kunkele, A.1
De Preter, K.2
Heukamp, L.3
Thor, T.4
Pajtler, K.W.5
Hartmann, W.6
Mittelbronn, M.7
Grotzer, M.A.8
Deubzer, H.E.9
Speleman, F.10
-
26
-
-
33845610993
-
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
-
Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006, 444: 761-765.
-
(2006)
Nature
, vol.444
, pp. 761-765
-
-
Piccirillo, S.G.1
Reynolds, B.A.2
Zanetti, N.3
Lamorte, G.4
Binda, E.5
Broggi, G.6
Brem, H.7
Olivi, A.8
Dimeco, F.9
Vescovi, A.L.10
-
27
-
-
4043147087
-
Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling
-
Rios I, Alvarez-Rodriguez R, Marti E, Pons S: Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 2004, 131: 3159-3168.
-
(2004)
Development
, vol.131
, pp. 3159-3168
-
-
Rios, I.1
Alvarez-Rodriguez, R.2
Marti, E.3
Pons, S.4
-
28
-
-
37549020350
-
Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc
-
Alvarez-Rodriguez R, Barzi M, Berenguer J, Pons S: Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. J Biol Chem 2007, 282: 37170-37180.
-
(2007)
J Biol Chem
, vol.282
, pp. 37170-37180
-
-
Alvarez-Rodriguez, R.1
Barzi, M.2
Berenguer, J.3
Pons, S.4
-
29
-
-
33745187327
-
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications
-
Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R: Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 2006, 13: 563-567.
-
(2006)
Chem Biol
, vol.13
, pp. 563-567
-
-
Lee, M.G.1
Wynder, C.2
Schmidt, D.M.3
McCafferty, D.G.4
Shiekhattar, R.5
-
30
-
-
79958247398
-
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor
-
Ogasawara D, Suzuki T, Mino K, Ueda R, Khan MN, Matsubara T, Koseki K, Hasegawa M, Sasaki R, Nakagawa H, et al.: Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor. Bioorg Med Chem 2011, 19: 3702-3708.
-
(2011)
Bioorg Med Chem
, vol.19
, pp. 3702-3708
-
-
Ogasawara, D.1
Suzuki, T.2
Mino, K.3
Ueda, R.4
Khan, M.N.5
Matsubara, T.6
Koseki, K.7
Hasegawa, M.8
Sasaki, R.9
Nakagawa, H.10
-
31
-
-
72249117352
-
Identification of cell-active lysine specific demethylase 1-selective inhibitors
-
Ueda R, Suzuki T, Mino K, Tsumoto H, Nakagawa H, Hasegawa M, Sasaki R, Mizukami T, Miyata N: Identification of cell-active lysine specific demethylase 1-selective inhibitors. J Am Chem Soc 2009, 131: 17536-17537.
-
(2009)
J Am Chem Soc
, vol.131
, pp. 17536-17537
-
-
Ueda, R.1
Suzuki, T.2
Mino, K.3
Tsumoto, H.4
Nakagawa, H.5
Hasegawa, M.6
Sasaki, R.7
Mizukami, T.8
Miyata, N.9
-
32
-
-
84875776185
-
KDM1 is a novel therapeutic target for the treatment of gliomas
-
Sareddy GR, Nair BC, Krishnan SK, Gonugunta VK, Zhang QG, Suzuki T, Miyata N, Brenner AJ, Brann DW, Vadlamudi RK: KDM1 is a novel therapeutic target for the treatment of gliomas. Oncotarget 2012, 4: 18-28.
-
(2012)
Oncotarget
, vol.4
, pp. 18-28
-
-
Sareddy, G.R.1
Nair, B.C.2
Krishnan, S.K.3
Gonugunta, V.K.4
Zhang, Q.G.5
Suzuki, T.6
Miyata, N.7
Brenner, A.J.8
Brann, D.W.9
Vadlamudi, R.K.10
-
33
-
-
80052266351
-
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
-
Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, et al.: Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011, 43: 875-878.
-
(2011)
Nat Genet
, vol.43
, pp. 875-878
-
-
Gui, Y.1
Guo, G.2
Huang, Y.3
Hu, X.4
Tang, A.5
Gao, S.6
Wu, R.7
Chen, C.8
Li, X.9
Zhou, L.10
-
34
-
-
80052029516
-
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
-
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, et al.: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476: 298-303.
-
(2011)
Nature
, vol.476
, pp. 298-303
-
-
Morin, R.D.1
Mendez-Lago, M.2
Mungall, A.J.3
Goya, R.4
Mungall, K.L.5
Corbett, R.D.6
Johnson, N.A.7
Severson, T.M.8
Chiu, R.9
Field, M.10
-
35
-
-
45549091581
-
Medulloblastoma stem cells
-
Fan X, Eberhart CG: Medulloblastoma stem cells. J Clin Oncol 2008, 26: 2821-2827.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2821-2827
-
-
Fan, X.1
Eberhart, C.G.2
-
36
-
-
77955175049
-
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
-
Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, et al.: Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466: 632-636.
-
(2010)
Nature
, vol.466
, pp. 632-636
-
-
Johnson, R.A.1
Wright, K.D.2
Poppleton, H.3
Mohankumar, K.M.4
Finkelstein, D.5
Pounds, S.B.6
Rand, V.7
Leary, S.E.8
White, E.9
Eden, C.10
-
37
-
-
27744450224
-
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation
-
Uziel T, Zindy F, Xie S, Lee Y, Forget A, Magdaleno S, Rehg JE, Calabrese C, Solecki D, Eberhart CG, et al.: The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev 2005, 19: 2656-2667.
-
(2005)
Genes Dev
, vol.19
, pp. 2656-2667
-
-
Uziel, T.1
Zindy, F.2
Xie, S.3
Lee, Y.4
Forget, A.5
Magdaleno, S.6
Rehg, J.E.7
Calabrese, C.8
Solecki, D.9
Eberhart, C.G.10
-
39
-
-
0034665673
-
Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3
-
Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y: Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 2000, 96: 2005-2011.
-
(2000)
Blood
, vol.96
, pp. 2005-2011
-
-
Kawamura, C.1
Kizaki, M.2
Yamato, K.3
Uchida, H.4
Fukuchi, Y.5
Hattori, Y.6
Koseki, T.7
Nishihara, T.8
Ikeda, Y.9
-
40
-
-
0042967678
-
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect
-
Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 2003, 9: 1033-1038.
-
(2003)
Nat Med
, vol.9
, pp. 1033-1038
-
-
Hallahan, A.R.1
Pritchard, J.I.2
Chandraratna, R.A.3
Ellenbogen, R.G.4
Geyer, J.R.5
Overland, R.P.6
Strand, A.D.7
Tapscott, S.J.8
Olson, J.M.9
-
41
-
-
41149130332
-
Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development
-
Zhao H, Ayrault O, Zindy F, Kim JH, Roussel MF: Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev 2008, 22: 722-727.
-
(2008)
Genes Dev
, vol.22
, pp. 722-727
-
-
Zhao, H.1
Ayrault, O.2
Zindy, F.3
Kim, J.H.4
Roussel, M.F.5
-
42
-
-
41749098048
-
The origins of medulloblastoma subtypes
-
Gilbertson RJ, Ellison DW: The origins of medulloblastoma subtypes. Annu Rev Pathol 2008, 3: 341-365.
-
(2008)
Annu Rev Pathol
, vol.3
, pp. 341-365
-
-
Gilbertson, R.J.1
Ellison, D.W.2
-
43
-
-
79955034739
-
Medulloblastoma comprises four distinct molecular variants
-
Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, et al.: Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011, 29: 1408-1414.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1408-1414
-
-
Northcott, P.A.1
Korshunov, A.2
Witt, H.3
Hielscher, T.4
Eberhart, C.G.5
Mack, S.6
Bouffet, E.7
Clifford, S.C.8
Hawkins, C.E.9
French, P.10
-
44
-
-
33847009559
-
Hedgehog signaling promotes medulloblastoma survival via Bc/II
-
Bar EE, Chaudhry A, Farah MH, Eberhart CG: Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol 2007, 170: 347-355.
-
(2007)
Am J Pathol
, vol.170
, pp. 347-355
-
-
Bar, E.E.1
Chaudhry, A.2
Farah, M.H.3
Eberhart, C.G.4
-
45
-
-
79960942643
-
Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells
-
Colvin Wanshura LE, Galvin KE, Ye H, Fernandez-Zapico ME, Wetmore C: Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells. Canc Res 2011, 71: 5336-5345.
-
(2011)
Canc Res
, vol.71
, pp. 5336-5345
-
-
Colvin Wanshura, L.E.1
Galvin, K.E.2
Ye, H.3
Fernandez-Zapico, M.E.4
Wetmore, C.5
-
46
-
-
0036192918
-
The WHO classification of tumors of the nervous system
-
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61: 215-225. discussion 226-219
-
(2002)
J Neuropathol Exp Neurol
, vol.61
, pp. 215-225
-
-
Kleihues, P.1
Louis, D.N.2
Scheithauer, B.W.3
Rorke, L.B.4
Reifenberger, G.5
Burger, P.C.6
Cavenee, W.K.7
-
47
-
-
0033050817
-
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study
-
Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, et al.: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999, 17: 832-845.
-
(1999)
J Clin Oncol
, vol.17
, pp. 832-845
-
-
Zeltzer, P.M.1
Boyett, J.M.2
Finlay, J.L.3
Albright, A.L.4
Rorke, L.B.5
Milstein, J.M.6
Allen, J.C.7
Stevens, K.R.8
Stanley, P.9
Li, H.10
-
48
-
-
84865296983
-
Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast
-
Serce N, Gnatzy A, Steiner S, Lorenzen H, Kirfel J, Buettner R: Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol 2012, 12: 13.
-
(2012)
BMC Clin Pathol
, vol.12
, pp. 13
-
-
Serce, N.1
Gnatzy, A.2
Steiner, S.3
Lorenzen, H.4
Kirfel, J.5
Buettner, R.6
-
49
-
-
84871956221
-
Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks Cancer Cell Invasion
-
Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, Manzotti G, Grisendi G, Dominici M, Pieraccioli M, et al.: Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks Cancer Cell Invasion. Canc Res 2012, 73: 235-245.
-
(2012)
Canc Res
, vol.73
, pp. 235-245
-
-
Ferrari-Amorotti, G.1
Fragliasso, V.2
Esteki, R.3
Prudente, Z.4
Soliera, A.R.5
Cattelani, S.6
Manzotti, G.7
Grisendi, G.8
Dominici, M.9
Pieraccioli, M.10
-
50
-
-
84859496098
-
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma
-
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D: A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One 2012, 7: e34705.
-
(2012)
PLoS One
, vol.7
-
-
Cheng, W.Y.1
Kandel, J.J.2
Yamashiro, D.J.3
Canoll, P.4
Anastassiou, D.5
-
51
-
-
79952020999
-
Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells
-
Gupta R, Chetty C, Bhoopathi P, Lakka S, Mohanam S, Rao JS, Dinh DE: Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. Int J Oncol 2011, 38: 733-744.
-
(2011)
Int J Oncol
, vol.38
, pp. 733-744
-
-
Gupta, R.1
Chetty, C.2
Bhoopathi, P.3
Lakka, S.4
Mohanam, S.5
Rao, J.S.6
Dinh, D.E.7
-
52
-
-
84871419643
-
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner
-
Jin L, Hanigan CL, Wu Y, Wang W, Park BH, Woster PM, Casero RA: Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner. Biochem J 2013, 449: 459-468.
-
(2013)
Biochem J
, vol.449
, pp. 459-468
-
-
Jin, L.1
Hanigan, C.L.2
Wu, Y.3
Wang, W.4
Park, B.H.5
Woster, P.M.6
Casero, R.A.7
-
53
-
-
70349739288
-
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism
-
Escoubet-Lozach L, Lin IL, Jensen-Pergakes K, Brady HA, Gandhi AK, Schafer PH, Muller GW, Worland PJ, Chan KW, Verhelle D: Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. Canc Res 2009, 69: 7347-7356.
-
(2009)
Canc Res
, vol.69
, pp. 7347-7356
-
-
Escoubet-Lozach, L.1
Lin, I.L.2
Jensen-Pergakes, K.3
Brady, H.A.4
Gandhi, A.K.5
Schafer, P.H.6
Muller, G.W.7
Worland, P.J.8
Chan, K.W.9
Verhelle, D.10
-
54
-
-
79957514394
-
HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance
-
Huang X, Wang S, Lee CK, Yang X, Liu B: HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. Canc Lett 2011, 307: 72-79.
-
(2011)
Canc Lett
, vol.307
, pp. 72-79
-
-
Huang, X.1
Wang, S.2
Lee, C.K.3
Yang, X.4
Liu, B.5
-
55
-
-
77958009878
-
HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells
-
Shimizu R, Kikuchi J, Wada T, Ozawa K, Kano Y, Furukawa Y: HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia 2010, 24: 1760-1768.
-
(2010)
Leukemia
, vol.24
, pp. 1760-1768
-
-
Shimizu, R.1
Kikuchi, J.2
Wada, T.3
Ozawa, K.4
Kano, Y.5
Furukawa, Y.6
-
56
-
-
80052743686
-
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
-
Singh MM, Manton CA, Bhat KP, Tsai WW, Aldape K, Barton MC, Chandra J: Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro Oncol 2011, 13: 894-903.
-
(2011)
Neuro Oncol
, vol.13
, pp. 894-903
-
-
Singh, M.M.1
Manton, C.A.2
Bhat, K.P.3
Tsai, W.W.4
Aldape, K.5
Barton, M.C.6
Chandra, J.7
-
57
-
-
84856230241
-
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells
-
Huang Y, Vasilatos SN, Boric L, Shaw PG, Davidson NE: Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Canc Res Treat 2012, 131: 777-789.
-
(2012)
Breast Canc Res Treat
, vol.131
, pp. 777-789
-
-
Huang, Y.1
Vasilatos, S.N.2
Boric, L.3
Shaw, P.G.4
Davidson, N.E.5
-
58
-
-
33747808580
-
Functional interplay between histone demethylase and deacetylase enzymes
-
Lee MG, Wynder C, Bochar DA, Hakimi MA, Cooch N, Shiekhattar R: Functional interplay between histone demethylase and deacetylase enzymes. Mol Cell Biol 2006, 26: 6395-6402.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 6395-6402
-
-
Lee, M.G.1
Wynder, C.2
Bochar, D.A.3
Hakimi, M.A.4
Cooch, N.5
Shiekhattar, R.6
-
59
-
-
84865864630
-
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation
-
Sprussel A, Schulte JH, Weber S, Necke M, Handschke K, Thor T, Pajtler KW, Schramm A, Konig K, Diehl L, et al.: Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 2012, 26: 2039-2051.
-
(2012)
Leukemia
, vol.26
, pp. 2039-2051
-
-
Sprussel, A.1
Schulte, J.H.2
Weber, S.3
Necke, M.4
Handschke, K.5
Thor, T.6
Pajtler, K.W.7
Schramm, A.8
Konig, K.9
Diehl, L.10
-
60
-
-
0037129827
-
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
-
RESEARCH0034
-
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3: RESEARCH0034.
-
(2002)
Genome Biol
, vol.3
-
-
Vandesompele, J.1
De Preter, K.2
Pattyn, F.3
Poppe, B.4
Van Roy, N.5
De Paepe, A.6
Speleman, F.7
-
61
-
-
19944432172
-
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
-
Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, et al.: Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 2005, 24: 165-177.
-
(2005)
Oncogene
, vol.24
, pp. 165-177
-
-
Schulte, J.H.1
Schramm, A.2
Klein-Hitpass, L.3
Klenk, M.4
Wessels, H.5
Hauffa, B.P.6
Eils, J.7
Eils, R.8
Brodeur, G.M.9
Schweigerer, L.10
-
62
-
-
28344437416
-
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
-
Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, Christiansen H, Warnat P, Brors B, Eils J, et al.: Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene 2005, 24: 7902-7912.
-
(2005)
Oncogene
, vol.24
, pp. 7902-7912
-
-
Schramm, A.1
Schulte, J.H.2
Klein-Hitpass, L.3
Havers, W.4
Sieverts, H.5
Berwanger, B.6
Christiansen, H.7
Warnat, P.8
Brors, B.9
Eils, J.10
-
63
-
-
60849139395
-
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
-
Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z: GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinforma 2009, 10: 48.
-
(2009)
BMC Bioinforma
, vol.10
, pp. 48
-
-
Eden, E.1
Navon, R.2
Steinfeld, I.3
Lipson, D.4
Yakhini, Z.5
-
64
-
-
0031837454
-
Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome
-
Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A: Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998, 4: 619-622.
-
(1998)
Nat Med
, vol.4
, pp. 619-622
-
-
Hahn, H.1
Wojnowski, L.2
Zimmer, A.M.3
Hall, J.4
Miller, G.5
Zimmer, A.6
-
65
-
-
7444228699
-
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
-
Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, Russell TL, Ellenbogen RG, Bernstein ID, Beachy PA, Olson JM: The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Canc Res 2004, 64: 7794-7800.
-
(2004)
Canc Res
, vol.64
, pp. 7794-7800
-
-
Hallahan, A.R.1
Pritchard, J.I.2
Hansen, S.3
Benson, M.4
Stoeck, J.5
Hatton, B.A.6
Russell, T.L.7
Ellenbogen, R.G.8
Bernstein, I.D.9
Beachy, P.A.10
Olson, J.M.11
|